希腊关于慢性淋巴细胞白血病 (CLL) 治疗的共识
Sotirios Sachanas1, Theodoros Vassilakopoulos2, Maria Angelopoulou2
1Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.
Mediterranean journal of hematology and infectious diseases
|March 14, 2025
概括
新的向疗法为慢性淋巴细胞白血病 (CLL) 患者提供了改善的结果. 治疗决策需要仔细考虑生物因素,患者偏好和安全概况,以实现最佳管理.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 新型向疗法的出现已经显著改变了慢性淋巴细胞白血病 (CLL) 治疗模式.
- 最佳的治疗策略需要对疾病生物学,个体患者特征和治疗安全性概况进行全面评估.
研究的目的:
- 为希腊CLL治疗提供基于共识的实践陈述.
- 指导临床医生在为一线和复发性/耐药性CLL设置中选择合适的治疗方法.
主要方法:
- 一个由希腊CLL专家组成的小组编写的共识实践声明.
- 对针对性疗法和CLL的治疗方法的现有证据的审查和综合.
主要成果:
- 确立了关于CLL一线治疗的建议.
- 为管理复发性或耐火性CLL病例提供了指导.
结论:
- 强调了个性化治疗选择在CLL的重要性.
- 强调需要在治疗决策中整合有效性,安全性和以患者为中心的因素.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chronic Pancreatitis II: Collaborative Care
54
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
54
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K


